Collectively, these results indicate that a multi-analyte interleukin panel, particularly IL-6 + IL-10 + IL-8 + IL-1RA, markedly improves diagnostic accuracy for NSCLC. This evidence concerns the gene CXCL8 and non-small cell lung carcinoma.